4//SEC Filing
TENAX THERAPEUTICS, INC. 4
Accession 0001354488-16-006306
$TENXCIK 0000034956operating
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:30 PM ET
Size
7.1 KB
Accession
0001354488-16-006306
Insider Transaction Report
Form 4
Mitchum James P.
Director
Transactions
- Purchase
Common Stock
2016-02-02$2.68/sh+5,100$13,668→ 5,100 total(indirect: By Trust) - Purchase
Common Stock
2016-02-03$2.65/sh+13,900$36,835→ 19,000 total(indirect: By Trust)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.66 to $2.69. The reporting person undertakes to provide to Tenax Therapeutics, Inc. (the ?Company?), any security holder of the Company, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.60 to $2.69.
Documents
Issuer
TENAX THERAPEUTICS, INC.
CIK 0000034956
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000034956
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:30 PM ET
- Size
- 7.1 KB